A Retrospective Study Investigating the Safety and Efficacy of Nanoliposomal Irinotecan in Elderly Patients with Unresectable Pancreatic Cancer

Although nanoliposomal irinotecan combined with 5-fluorouracil and leucovorin (nal-IRI+5-FU/LV) has been used to treat first-line resistant unresectable pancreatic cancer, the efficacy and safety data among the elderly remain limited. We retrospectively analyzed clinical outcomes among elderly patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikoma, Tatsuki, Matsumoto, Toshihiko, Boku, Shogen, Yasuda, Tomoyo, Masuda, Masataka, Ito, Takashi, Nakamaru, Koh, Yamaki, So, Nakayama, Shinji, Hashimoto, Daisuke, Yamamoto, Tomohisa, Shibata, Nobuhiro, Ikeura, Tsukasa, Naganuma, Makoto, Satoi, Sohei, Kurata, Takayasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218867/
https://www.ncbi.nlm.nih.gov/pubmed/37240585
http://dx.doi.org/10.3390/jcm12103477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218867/
https://www.ncbi.nlm.nih.gov/pubmed/37240585
http://dx.doi.org/10.3390/jcm12103477

Ejemplares similares